164 related articles for article (PubMed ID: 8240196)
1. Autonomic function and plasma catecholamines following stressful sensory stimuli.
Kohl RL
Aviat Space Environ Med; 1993 Oct; 64(10):921-7. PubMed ID: 8240196
[TBL] [Abstract][Full Text] [Related]
2. beta-Endorphin and arginine vasopressin following stressful sensory stimuli in man.
Kohl RL
Aviat Space Environ Med; 1992 Nov; 63(11):986-93. PubMed ID: 1332670
[TBL] [Abstract][Full Text] [Related]
3. Endocrine correlates of susceptibility to motion sickness.
Kohl RL
Aviat Space Environ Med; 1985 Dec; 56(12):1158-65. PubMed ID: 3002315
[TBL] [Abstract][Full Text] [Related]
4. Motion and space sickness: intestinal and autonomic correlates.
Muth ER
Auton Neurosci; 2006 Oct; 129(1-2):58-66. PubMed ID: 16950658
[TBL] [Abstract][Full Text] [Related]
5. Control of nausea and autonomic dysfunction with terfenadine, a peripherally acting antihistamine.
Kohl RL; Calkins DS; Robinson RE
Aviat Space Environ Med; 1991 May; 62(5):392-6. PubMed ID: 1675849
[TBL] [Abstract][Full Text] [Related]
6. The stability of individual patterns of autonomic responses to motion sickness stimulation.
Cowings PS; Naifeh KH; Toscano WB
Aviat Space Environ Med; 1990 May; 61(5):399-405. PubMed ID: 2350308
[TBL] [Abstract][Full Text] [Related]
7. Progressive dysregulation of autonomic and HPA axis functions in HIV-1 clade C infection in South India.
Chittiprol S; Kumar AM; Satishchandra P; Taranath Shetty K; Bhimasena Rao RS; Subbakrishna DK; Philip M; Satish KS; Ravi Kumar H; Kumar M
Psychoneuroendocrinology; 2008 Jan; 33(1):30-40. PubMed ID: 17993249
[TBL] [Abstract][Full Text] [Related]
8. Role of autonomic nervous system for development and suppression of motion sickness in Suncus murinus.
Uchino M; Ishii K; Kuwahara M; Ebukuro S; Tsubone H
Auton Neurosci; 2001 Dec; 94(1-2):46-51. PubMed ID: 11775707
[TBL] [Abstract][Full Text] [Related]
9. Reliability of psychophysiological responses across multiple motion sickness stimulation tests.
Stout CS; Toscano WB; Cowings PS
J Vestib Res; 1995; 5(1):25-33. PubMed ID: 7711945
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of antimotion sickness drug side effects on performance.
Wood CD; Manno JE; Manno BR; Redetzki HM; Wood MJ; Mims ME
Aviat Space Environ Med; 1985 Apr; 56(4):310-6. PubMed ID: 3888169
[TBL] [Abstract][Full Text] [Related]
11. Differences in autonomic responses between subjects with and without nausea while watching an irregularly oscillating video.
Himi N; Koga T; Nakamura E; Kobashi M; Yamane M; Tsujioka K
Auton Neurosci; 2004 Nov; 116(1-2):46-53. PubMed ID: 15556837
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of antimotion sickness drugs.
Wood CD; Manno JE; Wood MJ; Manno BR; Redetzki HM
Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A262-5. PubMed ID: 3675502
[TBL] [Abstract][Full Text] [Related]
13. Hormonal responses of metoclopramide-treated subjects experiencing nausea or emesis during parabolic flight.
Kohl RL
Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A266-9. PubMed ID: 2823788
[TBL] [Abstract][Full Text] [Related]
14. Illusory self-motion and motion sickness: a model for brain-gut interactions and nausea.
Koch KL
Dig Dis Sci; 1999 Aug; 44(8 Suppl):53S-57S. PubMed ID: 10490040
[TBL] [Abstract][Full Text] [Related]
15. Histaminergic response to Coriolis stimulation: implication for transdermal scopolamine therapy of motion sickness.
Wang ET; Zhou DR; He LH
Aviat Space Environ Med; 1992 Jul; 63(7):579-82. PubMed ID: 1616432
[TBL] [Abstract][Full Text] [Related]
16. [Effects of vestibular stimulus on heart rate variability].
Tian G; Yu Y; Hu S; Bai G; Gu Y; Gai Y
Space Med Med Eng (Beijing); 1998 Dec; 11(6):401-5. PubMed ID: 11543375
[TBL] [Abstract][Full Text] [Related]
17. Antimotion-sickness efficacy of scopolamine 12 and 72 hours after transdermal administration.
Graybiel A; Cramer DB; Wood CD
Aviat Space Environ Med; 1982 Aug; 53(8):770-2. PubMed ID: 7181807
[TBL] [Abstract][Full Text] [Related]
18. Phenytoin for motion sickness: clinical evaluation.
Knox GW; Woodard D; Chelen W; Ferguson R; Johnson L
Laryngoscope; 1994 Aug; 104(8 Pt 1):935-9. PubMed ID: 8052077
[TBL] [Abstract][Full Text] [Related]
19. Experimental motion sickness: efficacy of transdermal scopolamine plus ephedrine.
Graybiel A; Cramer DB; Wood CD
Aviat Space Environ Med; 1981 Jun; 52(6):337-9. PubMed ID: 7259691
[TBL] [Abstract][Full Text] [Related]
20. Diazepam as an anti-motion sickness drug.
McClure JA; Lycett P; Baskerville JC
J Otolaryngol; 1982 Aug; 11(4):253-9. PubMed ID: 7131636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
